Innovative cardiovascular systems announce first use of its next-generation Emblok embolic protection system in European feasibility study
Ngày 12/03/2019 11:03 | Lượt xem: 142

Innovative Cardiovascular Solutions (ICS) has announced the first clinical use of its next-generation Emblok embolic protection system in patients undergoing transcatheter aortic valve implantation (TAVI) procedures in its European feasibility study. The cases were successfully performed by primary investigator Federico De Marco (Policlinico San Donato, Milan, Italy).

The Emblok system is designed for use in TAVI and other structural heart procedures, which are associated with an increased risk of neurological events compared to conventional surgery due to embolic debris that is liberated throughout the procedure. A press release reports that the next-generation Emblok system is the first embolic protection system to fully protect the cerebral, abdominal and peripheral vasculature with complete circumferential aortic coverage to capture and remove the liberated embolic debris throughout the entire TAVI procedure.

In addition to offering protection to more patients, according to the press release, the next-generation Emblok system provides protection throughout the entire TAVI procedure. The embolic filter deploys before the TAVI catheter enters the aorta and remains deployed until the TAVI catheter is removed.

De Marco comments: “I am excited to have one embolic protection system I can use across nearly all my TAVI patients to provide complete protection during the entire TAVI procedure. There is nothing like it on the market.”

R Kevin Plemmons, CEO of ICS, says: “The prior generation demonstrated excellent performance, however we saw an opportunity to modify the device dimensions to be suitable for even more patients. The next-generation Emblok system is appropriate for 97% of all TAVI patients, whereas other commercial embolic protection devices may not be suitable for all anatomies.”

The entire system is 11F and allows both the embolic filter and integrated pigtail catheter to be deployed through a single femoral access site. The Emblok system is available for investigational use only and is not approved for sale. The company plans to begin its US  early feasibility study later this year. Study endpoints will include acute cerebral embolic burden and major adverse cardiac and cerebrovascular events (MACCE) at 30 days.

Source CardiovascularNews
Duc Tin Clinic
Print Chia sẽ qua facebook bài: Innovative cardiovascular systems announce first use of its next-generation Emblok embolic protection system in European feasibility study Chia sẽ qua google bài: Innovative cardiovascular systems announce first use of its next-generation Emblok embolic protection system in European feasibility study Chia sẽ qua twitter bài: Innovative cardiovascular systems announce first use of its next-generation Emblok embolic protection system in European feasibility study Chia sẽ qua MySpace bài: Innovative cardiovascular systems announce first use of its next-generation Emblok embolic protection system in European feasibility study Chia sẽ qua LinkedIn bài: Innovative cardiovascular systems announce first use of its next-generation Emblok embolic protection system in European feasibility study Chia sẽ qua stumbleupon bài: Innovative cardiovascular systems announce first use of its next-generation Emblok embolic protection system in European feasibility study Chia sẽ qua icio bài: Innovative cardiovascular systems announce first use of its next-generation Emblok embolic protection system in European feasibility study Chia sẽ qua digg bài: Innovative cardiovascular systems announce first use of its next-generation Emblok embolic protection system in European feasibility study Chia sẽ qua yahoo bài: Innovative cardiovascular systems announce first use of its next-generation Emblok embolic protection system in European feasibility study Chia sẽ qua yahoo bài: Innovative cardiovascular systems announce first use of its next-generation Emblok embolic protection system in European feasibility study Chia sẽ qua yahoo bài: Innovative cardiovascular systems announce first use of its next-generation Emblok embolic protection system in European feasibility study Chia sẽ qua yahoo bài: Innovative cardiovascular systems announce first use of its next-generation Emblok embolic protection system in European feasibility study

Tin tức liên quan

CUSTOMER REVIEWS

  • I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

    I sincerely thank you !. Tel: 0938303275

  • Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

    Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

  • As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

  • The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

  • I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.

Search
Customer support

    Phone: (028) 3981 2678
    Mobile: 0903 839 878 - 0909 384 389

TOP